ANNORA PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANNORA PHARMA, and what generic and branded alternatives to ANNORA PHARMA drugs are available?
ANNORA PHARMA has forty-one approved drugs.
There are four tentative approvals on ANNORA PHARMA drugs.
Summary for ANNORA PHARMA
US Patents: | 0 |
Tradenames: | 34 |
Ingredients: | 34 |
NDAs: | 41 |
Patent Litigation for ANNORA PHARMA: | See patent lawsuits for ANNORA PHARMA |
Drugs and US Patents for ANNORA PHARMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annora Pharma | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 215939-001 | Jan 11, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | NABUMETONE | nabumetone | TABLET;ORAL | 090445-002 | Jan 12, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | DEFERASIROX | deferasirox | TABLET;ORAL | 214341-002 | May 14, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | DEFERASIROX | deferasirox | TABLET;ORAL | 214341-003 | May 14, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | MESALAMINE | mesalamine | TABLET, DELAYED RELEASE;ORAL | 216334-001 | Feb 5, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | SAPROPTERIN DIHYDROCHLORIDE | sapropterin dihydrochloride | TABLET;ORAL | 215534-001 | Aug 23, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.